While we did not see a higher TNF-α transcript level in laryngeal cancer patients and in all TNM stages, a study by Andersson et al. [15] pointed upregulation of TNF-α as potential biomarker of shorter patient survival independent of clinical stage. The gene discussed is TNF; the disease is laryngeal carcinoma.